BG
TARO

BlackRock Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BlackRock Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.89M Buy
55,913
+9,814
+21% +$1.03M ﹤0.01% 1096
2016
Q3 		$5.09M Buy
46,099
+2,333
+5% +$309K ﹤0.01% 1102
2016
Q2 		$6.37M Buy
43,766
+14,316
+49% +$2.03M ﹤0.01% 1011
2016
Q1 		$4.22M Buy
29,450
+8,854
+43% +$1.26M ﹤0.01% 1143
2015
Q4 		$3.18M Buy
+20,596
New +$3.01M ﹤0.01% 1252

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Group's TARO Position: Q4 2016 in Review

BlackRock Group increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 21% in Q4 2016, buying an estimated $1.03M and bringing the position to 55,913 shares worth $5.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

BlackRock Group first reported a position in TARO in Q4 2015 and has held it in 5 quarters since. The position peaked at $6.37M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • BlackRock Group held 55,913 shares of Taro Pharmaceutical Industries Ltd. worth $5.89M as of Q4 2016.
  • BlackRock Group bought 9,814 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $1.03M.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1096 holding.
  • BlackRock Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Group's Taro Pharmaceutical Industries Ltd. position peaked at $6.37M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.